DK174289A - Anvendelse af 3-substituerede 2-oxindol-1-carboxamid forbindelser til fremstilling af farmaceutiske praeparater til undertrykkelse af t-celle-funktion - Google Patents

Anvendelse af 3-substituerede 2-oxindol-1-carboxamid forbindelser til fremstilling af farmaceutiske praeparater til undertrykkelse af t-celle-funktion

Info

Publication number
DK174289A
DK174289A DK174289A DK174289A DK174289A DK 174289 A DK174289 A DK 174289A DK 174289 A DK174289 A DK 174289A DK 174289 A DK174289 A DK 174289A DK 174289 A DK174289 A DK 174289A
Authority
DK
Denmark
Prior art keywords
cell function
substituted
oxindol
representation
preparation
Prior art date
Application number
DK174289A
Other languages
English (en)
Other versions
DK174289D0 (da
Inventor
Henry James Showell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK174289D0 publication Critical patent/DK174289D0/da
Publication of DK174289A publication Critical patent/DK174289A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK174289A 1988-04-13 1989-04-12 Anvendelse af 3-substituerede 2-oxindol-1-carboxamid forbindelser til fremstilling af farmaceutiske praeparater til undertrykkelse af t-celle-funktion DK174289A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/181,142 US4853409A (en) 1988-04-13 1988-04-13 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Publications (2)

Publication Number Publication Date
DK174289D0 DK174289D0 (da) 1989-04-12
DK174289A true DK174289A (da) 1989-10-16

Family

ID=22663072

Family Applications (1)

Application Number Title Priority Date Filing Date
DK174289A DK174289A (da) 1988-04-13 1989-04-12 Anvendelse af 3-substituerede 2-oxindol-1-carboxamid forbindelser til fremstilling af farmaceutiske praeparater til undertrykkelse af t-celle-funktion

Country Status (17)

Country Link
US (1) US4853409A (da)
EP (1) EP0337628B1 (da)
JP (1) JPH01311022A (da)
KR (1) KR920002328B1 (da)
AT (1) ATE89725T1 (da)
AU (1) AU601326B2 (da)
CA (1) CA1324762C (da)
DE (1) DE68906707T2 (da)
DK (1) DK174289A (da)
HU (1) HU204996B (da)
IE (1) IE62751B1 (da)
IL (1) IL89872A (da)
MY (1) MY103872A (da)
NZ (1) NZ228712A (da)
PH (1) PH25857A (da)
PT (1) PT90249B (da)
ZA (1) ZA892622B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DK0680321T3 (da) * 1993-01-22 1999-06-14 Pfizer Lysinsalt af 6-chlor-5-fluor-3-(2-thenoyl)-2-oxindol-1-carboxamid
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US5545656A (en) * 1995-04-05 1996-08-13 Pfizer Inc. 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
SK281254B6 (sk) * 1995-07-13 2001-01-18 Smithkline Beecham Corporation Použitie@kán-2-propánamínu, farmaceutický prostriedok s jeho obsahom a jeho použitie
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
WO2006105796A1 (en) * 2005-04-08 2006-10-12 Leo Pharma A/S Novel indolinone derivatives
EP2886541A1 (en) * 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3413572A1 (de) * 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt Oxindol-verbindungen zur behandlung der epilepsie
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
AU6898287A (en) * 1986-01-30 1987-08-25 University Of Utah, The Treatment of bone loss
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Also Published As

Publication number Publication date
DE68906707D1 (de) 1993-07-01
IL89872A (en) 1994-06-24
MY103872A (en) 1993-09-30
HUT52376A (en) 1990-07-28
IL89872A0 (en) 1989-12-15
ZA892622B (en) 1990-11-28
PT90249A (pt) 1989-11-10
JPH01311022A (ja) 1989-12-15
EP0337628B1 (en) 1993-05-26
KR890015740A (ko) 1989-11-25
AU3271289A (en) 1989-10-19
AU601326B2 (en) 1990-09-06
KR920002328B1 (ko) 1992-03-21
HU204996B (en) 1992-03-30
PT90249B (pt) 1994-06-30
DE68906707T2 (de) 1993-09-16
ATE89725T1 (de) 1993-06-15
IE62751B1 (en) 1995-02-22
EP0337628A2 (en) 1989-10-18
EP0337628A3 (en) 1991-01-02
US4853409A (en) 1989-08-01
DK174289D0 (da) 1989-04-12
CA1324762C (en) 1993-11-30
PH25857A (en) 1991-12-02
NZ228712A (en) 1997-02-24
IE891171L (en) 1989-10-13

Similar Documents

Publication Publication Date Title
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
ES479474A1 (es) Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral.
SE8505112D0 (sv) Novel pharmacological compounds
DK174289A (da) Anvendelse af 3-substituerede 2-oxindol-1-carboxamid forbindelser til fremstilling af farmaceutiske praeparater til undertrykkelse af t-celle-funktion
DK95091D0 (da) Anvendelse af acetyl-d-carnitin ved terapeutisk behandling af glaucoma
DK174389A (da) Anvendelse af 3-substituerede 2-oxindol-1-carboxamid-forbindelser til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-biosyntese
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
DK248886A (da) Spiro-imidazolidin-forbindelser og farmaceutiske praeparater indeholdende disse
DK52685D0 (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
DE68912376D1 (de) Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie.
DK148288D0 (da) N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne
DK520787D0 (da) Terapeutisk middel indeholdende propentofyllin eller derivater deraf til brug ved behandling af peptisk ulcus
DK131188D0 (da) 3-(2-halogenalkyl)-1,4-oxathiiner og 2(2-halogenalkyl)-1,4-dithiiner, samt farmaceutiske praeparater indeholdende disse til behandling af leukaemi og tumorer
DK0428107T3 (da) Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til behandling af multidrugresistente tumorer
IT1145433B (it) Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione
ES2053808T3 (es) Nuevos compuestos azolicos.
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.
DE69002027D1 (de) (3-diethylaminopropyl)-1-amino-5-methyldipyrido(4,3-b)(3,4-f)indoltrihydrochlorid.
DK461089D0 (da) Farmaceutiske praeparater til behandling af cardiovasculaere sygdomme
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
IT8722713A0 (it) Composizioni farmaceutiche topiche contenenti antiistaminici h2
NO903408D0 (no) Terapeutisk anvendelse av anti-t-celle-immunotoksin for autoimmunsykdommer.
IT8720229A0 (it) Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
AHS Application shelved for other reasons than non-payment